Publication
An evaluation of becotatug vedotin for the treatment of recurrent or metastatic nasopharyngeal cancer.
Xiaohui Wang, Fei Han
Expert opinion on biological therapySep 1, 2026PMID 42636063doi:10.1080/14712598.2026.2721409 Journal ArticleReviewpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
INTRODUCTION: Recurrent or metastatic nasopharyngeal carcinoma (R/M NPC) remains a significant clinical challenge despite advances in chemoradiation, with approximately 30% of patients ultimately developing R/M disease. There is an ongoing unmet need for novel therapeutic approaches that improve…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Nasopharyngeal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.